Basic Information
| RNALocate ID: | RLID:11004370 |
| RNA Symbol: | hsa-miR-320d |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-320d |
| RNA ID: | miRBase:MIMAT0006764 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 20976003 |
| Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
| Method: | Microarray |
| Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002800 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11004369 | Exosome | Pooled sera | 27278097 |
| RLID:11004371 | Exosome | Plasma | 23663360 |
| RLID:11004372 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11004373 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11004374 | Microvesicle | Plasma | 23077538 |
| RLID:11004375 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000804 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001744 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-320d | Ovarian clear cell carcinoma | MNDR-E-MI-39497 |
| MNDR | hsa-miR-320d | Estrogen-receptor positive breast cancer | MNDR-E-MI-39498 |
| MNDR | hsa-miR-320d | Estrogen-receptor negative breast cancer | MNDR-E-MI-39499 |
| MNDR | hsa-miR-320d | Progesterone-receptor positive breast cancer | MNDR-E-MI-39500 |
| MNDR | hsa-miR-320d | Progesterone-receptor negative breast cancer | MNDR-E-MI-39501 |
| MNDR | hsa-miR-320d | Her2-receptor positive breast cancer | MNDR-E-MI-39502 |
| MNDR | hsa-miR-320d | Prostate cancer | MNDR-E-MI-39503 |
| MNDR | hsa-miR-320d | Gastric cancer | MNDR-E-MI-39504 |
| MNDR | hsa-miR-320d | Alzheimer disease | MNDR-E-MI-39505 |
| MNDR | hsa-miR-320d | Intracranial aneurysm | MNDR-E-MI-39506 |
| MNDR | hsa-miR-320d | Cardiovascular disease | MNDR-E-MI-39507 |
| MNDR | hsa-miR-320d | Moyamoya disease | MNDR-E-MI-39508 |
| MNDR | hsa-miR-320d | Lung cancer | MNDR-E-MI-39509 |
| MNDR | hsa-miR-320d | Parkinson disease | MNDR-E-MI-39510 |
| MNDR | hsa-miR-320d | Breast cancer | MNDR-E-MI-39511 |
| MNDR | hsa-miR-320d | Pancreatic cancer | MNDR-E-MI-39512 |
| MNDR | hsa-miR-320d | Nephroblastoma | MNDR-E-MI-39513 |
| MNDR | hsa-miR-320d | Colon cancer | MNDR-E-MI-39514 |
| MNDR | hsa-miR-320d | Relapsing-remitting multiple sclerosis | MNDR-E-MI-39515 |
| MNDR | hsa-miR-320d | Familial ovarian cancer | MNDR-E-MI-39516 |
| MNDR | hsa-miR-320d | Prostate adenocarcinoma | MNDR-E-MI-39517 |
| MNDR | hsa-miR-320d | Carcinoma ductal breast | MNDR-E-MI-39518 |
| MNDR | hsa-miR-320d | Glioblastoma | MNDR-E-MI-39519 |
| MNDR | hsa-mir-320d | Glioma | MNDR-E-MI-39520 |
| MNDR | hsa-miR-320d | Chronic obstructive pulmonary disease | MNDR-E-MI-39521 |
| MNDR | hsa-miR-320d | Chordoma | MNDR-E-MI-39522 |
| MNDR | hsa-miR-320d | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39523 |
| MNDR | hsa-miR-320d | Lung squamous cell carcinoma | MNDR-E-MI-39524 |
| MNDR | hsa-miR-320d | Non-small cell lung adenocarcinoma | MNDR-E-MI-39525 |
| MNDR | hsa-miR-320d | Lung adenocarcinoma | MNDR-E-MI-39526 |
| MNDR | hsa-miR-320d | Adrenocortical cancer | MNDR-E-MI-39527 |
| MNDR | hsa-miR-320d | Thyroid carcinoma | MNDR-E-MI-39528 |
| MNDR | hsa-miR-320d | Pancreatic adenocarcinoma | MNDR-E-MI-39529 |
| MNDR | hsa-miR-320d | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39530 |
| MNDR | hsa-miR-320d | Kidney renal clear cell carcinoma | MNDR-E-MI-39531 |
| MNDR | hsa-miR-320d | Renal clear cell carcinoma | MNDR-E-MI-39532 |
| MNDR | hsa-miR-320d | Biliary tract cancer | MNDR-E-MI-39533 |
| MNDR | hsa-miR-320d | Head and neck squamous cell carcinoma | MNDR-E-MI-39534 |
| MNDR | hsa-miR-320d | Breast invasive carcinoma | MNDR-E-MI-39535 |
| MNDR | hsa-miR-320d | Familiar ovarian carcinoma | MNDR-E-MI-39536 |
| MNDR | hsa-miR-320d | B-cell lymphoma | MNDR-E-MI-39537 |
| MNDR | hsa-miR-320d | Rheumatoid arthritis | MNDR-E-MI-39538 |
| MNDR | hsa-miR-320d | Retinoblastoma | MNDR-E-MI-39539 |
| MNDR | hsa-miR-320d | Skin cutaneous melanoma | MNDR-E-MI-39540 |
| MNDR | hsa-miR-320d | Skin melanoma | MNDR-E-MI-39541 |
| MNDR | hsa-miR-320d | Colorectal cancer | MNDR-E-MI-39542 |
| MNDR | hsa-miR-320d | Stroke lacunar | MNDR-E-MI-39543 |
| MNDR | hsa-miR-320d | Breast cancer her3+ negative | MNDR-E-MI-39544 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABHD13 | Homo sapiens | RR00025355 |
TOP